Vivos Therapeutics, Inc.
Vivos Therapeutics, Inc. (VVOS) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · VVOS · as of Sep 30, 2025
Ownership Breakdown
22
Institutional Holders
▲ 4 vs Q2
$2.13M
Total Inst. Value
▲ $857,977 vs Q2
5.89M
Shares Outstanding
freeFloat 54.21%
686,727
13F Shares Held
▲ 284,645 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
VVOS largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
CONNECTIVE CAPITAL MANAGEMENT, LLC surgical & medical instruments & apparatus | 200.0K | 2.20% | 2.20% | $620.00M | Nov 17, 2025 | NEW |
STRATEGIC WEALTH INVESTMENT GROUP, LLC surgical & medical instruments & apparatus | 100.0K | 1.10% | 1.10% | $310.00M | Nov 14, 2025 | NEW |
VANGUARD GROUP INC surgical & medical instruments & apparatus | 91.5K | 1.01% | 1.01% | $283.53M | Nov 7, 2025 | ▲ 48.8K |
GEODE CAPITAL MANAGEMENT, LLC surgical & medical instruments & apparatus | 53.3K | 58.64% | 58.64% | $165.19M | Nov 12, 2025 | ▼ 4.6K |
B. RILEY WEALTH ADVISORS, INC. surgical & medical instruments & apparatus | 43.5K | 47.90% | 47.90% | $134.95M | Oct 31, 2025 | ▼ 26.0K |
DRW SECURITIES, LLC surgical & medical instruments & apparatus | 41.5K | 45.63% | 45.63% | $128.54M | Nov 14, 2025 | NEW |
COMMONWEALTH EQUITY SERVICES, LLC surgical & medical instruments & apparatus | 41.0K | 45.12% | 45.12% | $127.00M | Oct 22, 2025 | — held |
RENAISSANCE TECHNOLOGIES LLC surgical & medical instruments & apparatus | 39.3K | 43.22% | 43.22% | $121.77M | Nov 13, 2025 | NEW |
BLACKROCK, INC. surgical & medical instruments & apparatus | 27.8K | 30.61% | 30.61% | $86.23M | Nov 12, 2025 | NEW |
STATE STREET CORP surgical & medical instruments & apparatus | 24.9K | 27.43% | 27.43% | $77.26M | Nov 14, 2025 | ▲ 13.1K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
4
Increased
+70.0K shares7
New Positions
first time holders4
Decreased
−173.3K shares3
Sold Out
fully exitedNet shares change (top 50)
103.3K
+70.0K / −173.3K
Net new holders
+4
7 new / 3 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
VVOS insider trading · insider activity
Source: SEC Form 4
Insiders have been net buyers of shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
5
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Skaff Michael C 10 percent owner | Mar 31, 2026 | Purchase | 1,783,582 | $1.09 | $1.94M | 1.78M | Form 4 ↗ |
Skaff Michael C 10 percent owner | Mar 31, 2026 | Purchase | 1,783,582 | $1.09 | $1.94M | 1.78M | Form 4 ↗ |
Skaff Michael C 10 percent owner | Mar 31, 2026 | Purchase | 308,848 | $1.34 | $413.9K | 1.35M | Form 4 ↗ |
Skaff Michael C 10 percent owner | Mar 31, 2026 | Purchase | 1,044,777 | $1.34 | $1.40M | 1.04M | Form 4 ↗ |
Skaff Michael C 10 percent owner | Mar 31, 2026 | Purchase | 429,957 | $0.00 | $42.996 | 430.0K | Form 4 ↗ |
Huntsman Ronald Kirk Chief Executive Officer | Nov 26, 2024 | Award | 315,421 | $2.64 | $832.7K | 364.8K | Form 4 ↗ |
Amman Bradford K. Chief Financial Officer | Nov 26, 2024 | Award | 149,533 | $2.64 | $394.8K | 180.5K | Form 4 ↗ |
Huntsman Ronald Kirk Chief Executive Officer | Jun 20, 2024 | Award | 20,000 | $2.38 | $47.6K | 49.3K | Form 4 ↗ |
SOKOLOW LEONARD J director | Jun 20, 2024 | Award | 4,000 | $2.38 | $9.5K | 7.5K | Form 4 ↗ |
Thompson Matthew director | Jun 20, 2024 | Award | 4,000 | $2.38 | $9.5K | 7.1K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Vivos Therapeutics, Inc. (VVOS) is primarily owned by institutional investors, who hold approximately 11.7% of total shares outstanding. Company insiders own approximately 45.79%, while retail and public investors account for the remaining 42.55%.
The largest institutional shareholder of Vivos Therapeutics, Inc. is CONNECTIVE CAPITAL MANAGEMENT, LLC, holding approximately 200,000 shares — equal to 2.20% of outstanding shares — as of September 30, 2025.
A total of 22 institutional investors currently hold VVOS stock, with a combined institutional value of approximately $2,129,135 as of the most recent 13F filing period.
Frequently asked questions
VVOS ownershipVivos Therapeutics, Inc. (VVOS) is primarily owned by institutional investors, who hold approximately 11.7% of shares. The largest shareholder is CONNECTIVE CAPITAL MANAGEMENT, LLC with a 2.20% stake. Company insiders hold 45.79%. Data sourced from SEC Form 13F as of September 30, 2025.